Evidence map›Paper›PMID 39871998›Full record

ArticleIn vitro models2023

Interlaboratory comparison of an intestinal triple culture to confirm transferability and reproducibility.

Angela A M Kämpfer, Ume-Kulsoom Shah, Shui L Chu, Mathias Busch, Veronika Büttner, Ruiwen He, Barbara Rothen-Rutishauser, Roel P F Schins, Gareth J Jenkins

Abstract read
In one paragraph

Article in In vitro models, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela A M KämpferIUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Ume-Kulsoom ShahSchool of Medicine, Faculty of Medicine, Health and Life Science, Swansea, Wales UK.
Shui L ChuAdolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.
Mathias BuschIUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Veronika BüttnerIUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Ruiwen HeAdolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.
Barbara Rothen-RutishauserAdolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.
Roel P F SchinsIUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Gareth J JenkinsSchool of Medicine, Faculty of Medicine, Health and Life Science, Swansea, Wales UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and improvement of advanced intestinal in vitro models has received increasing attention in recent years. While the availability of relevant in vitro models is pivotal to advance the replacement and reduction of animal use in research, their robustness is a crucial determinant for intra- and interlaboratory reproducibility. We have developed a standard protocol to build a triple culture model combining two types of human intestinal epithelial cells (Caco-2, HT29-MTX-E12) and macrophages (THP-1), which was tested for transferability and reproducibility between three laboratories. The epithelial tissue barrier development and triple culture stability were investigated as well as the models' responses to the non-steroidal anti-inflammatory drug diclofenac in terms of barrier integrity, cytotoxicity, and cytokine release. The results of two partner laboratories were compared to previously established benchmark results and quality criteria. For the epithelial co-cultures, the results were overall highly comparable between the laboratories. The addition of THP-1 cells resulted in increased variability and reduced reproducibility. While good correlation was achieved in several endpoints, others showed substantial response differences between the laboratories. Some variations may be addressed with training or demonstrations, whereas others might be related to fundamental differences in the cell lines introduced during routine cell culture and maintenance. Our results underline the importance of interlaboratory transfer studies using standardised experimental procedures, including defined quality criteria and benchmarks, as well as of training when newly establishing complex in vitro models in laboratories. Supplementary Information: The online version contains supplementary material available at 10.1007/s44164-022-00025-w.

Indexed as

DiclofenacEnterotoxicityInterlaboratory comparisonNew approach methodologiesReproducibility

Identifiers

PMID39871998
PMCPMC11756443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.